Positron emission tomography (PET) is a powerful technique with the sensitivity to image and quantify receptor-bound radioligands in vivo. Recent progress in PET scanner technology has resulted in the development of dedicated tomographs designed for small animals, with resolution that allows the delineation of discrete organs and their larger substructures in rats and mice. Our aim was to determine whether endothelin-1 (ET-1) could be labelled with 18F, and whether the resulting 18F-ET-1 would have the required pharmacokinetic properties to permit binding and imaging of ET receptors in vivo. 18F-ET-1 could be produced in a total radiochemical yield of 5.9±0.7% in 207±3min (n = 20). Specific radioactivities were in the range 220–370GBq/µmol, and the radiochemical purity of the isolated 18F-ET-1 was >95%. In vivo distribution in the rat was studied using microPET. High levels of 18F-ET-1 uptake were found in lung and kidney, whereas liver showed moderate levels of uptake. The resolution of the microPET scanner was sufficient to differentiate heterogeneous uptake in subrenal structures in the rat.
Skip Nav Destination
Article navigation
September 2002
-
Cover Image
Cover Image
Conference Article|
September 01 2002
18F-Endothelin-1, a positron emission tomography (PET) radioligand for the endothelin receptor system: radiosynthesis and in vivo imaging using microPET
Peter JOHNSTRÖM;
*Clinical Pharmacology Unit, University of Cambridge, Level 6, Centre for Clinical Investigation, Box 110, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
Dr Peter Johnström (e-mail [email protected]).
Search for other works by this author on:
Neil G. HARRIS;
Neil G. HARRIS
†Cambridge Centre for Brain Repair, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
‡Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
§Academic Neurosurgery, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
Search for other works by this author on:
Tim D. FRYER;
Tim D. FRYER
‡Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
Search for other works by this author on:
Olivier BARRET;
Olivier BARRET
‡Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
Search for other works by this author on:
John C. CLARK;
John C. CLARK
‡Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
Search for other works by this author on:
John D. PICKARD;
John D. PICKARD
†Cambridge Centre for Brain Repair, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
‡Wolfson Brain Imaging Centre, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
§Academic Neurosurgery, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
Search for other works by this author on:
Anthony P. DAVENPORT
Anthony P. DAVENPORT
§Academic Neurosurgery, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2002 The Biochemical Society and the Medical Research Society
2002
Clin Sci (Lond) (2002) 103 (s2002): 4S–8S.
Citation
Peter JOHNSTRÖM, Neil G. HARRIS, Tim D. FRYER, Olivier BARRET, John C. CLARK, John D. PICKARD, Anthony P. DAVENPORT; 18F-Endothelin-1, a positron emission tomography (PET) radioligand for the endothelin receptor system: radiosynthesis and in vivo imaging using microPET. Clin Sci (Lond) 1 September 2002; 103 (s2002): 4S–8S. doi: https://doi.org/10.1042/CS103S004S
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |